NIH-funded research NIH-funded research

NST-SPARK: AR app to help negative symptoms in schizophrenia

Official title: NST-SPARK: Developing an Augmented Reality (AR) Digital Health Intervention for Negative Symptoms in Schizophrenia

Funded at North Shore Therapeutics, INC. · NIH-11315398 · Data updated 2026-11-12

A smartphone AR therapy called NST-SPARK aims to help adults with schizophrenia reduce negative symptoms like lack of motivation and pleasure.

Quick facts

Grant typeNIH-funded research
Study typeNIH-funded research
Funding institutionNorth Shore Therapeutics, INC.
NIH-funded
Lab location1 site (Rochester, UNITED STATES)
Project startSeptember 1, 2026
Project endAugust 31, 2028
Funding year2026
Award (this year)$450,020
NIH project number1R41MH140642-01A1
Project IDNIH-11315398 on NIH RePORTER

Who could benefit from this research

Could help

Adults 21 years and older with schizophrenia spectrum disorders experiencing noticeable negative symptoms.

Less likely to help

Individuals without significant negative symptoms or those unable to use smartphone AR tools may not benefit.

What this research studies

This project develops a smartphone-based augmented reality therapy that delivers Recovery-oriented Cognitive Therapy through gamified AR experiences to change unhelpful beliefs contributing to negative symptoms. It involves co-design with people who have lived experience and a 12-week treatment course delivered in two phases. The first phase focuses on refining the app with user input, while the second phase tests the 12-week program in adults with schizophrenia spectrum disorders who have moderate to severe negative symptoms.

Why it matters

Potential benefit: If successful, NST-SPARK could offer a new, engaging tool to lessen negative symptoms and improve daily functioning.

How similar studies have gone: Preliminary results suggest feasibility and acceptability, with potential symptom-belief reductions observed in prior work.

Where this research is happening

  • North Shore Therapeutics, INC.
    Rochester, United States
    Active

Researchers

  • Principal investigator: Cronin, William Francis — North Shore Therapeutics, INC.
  • Study coordinator: Cronin, William Francis

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.